Shattuck Labs, Inc. (STTK)
5.655
-0.20
(-3.50%)
USD |
NASDAQ |
Oct 07, 16:00
5.65
0.00 (0.00%)
After-Hours: 20:00
Shattuck Labs Debt to Equity Ratio : 0.0127 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0127 |
| March 31, 2026 | 0.0301 |
| December 31, 2025 | 0.0294 |
| September 30, 2025 | 0.0282 |
| June 30, 2025 | 0.0521 |
| March 31, 2025 | 0.0472 |
| December 31, 2024 | 0.0428 |
| September 30, 2024 | 0.0374 |
| June 30, 2024 | 0.0345 |
| March 31, 2024 | 0.0312 |
| December 31, 2023 | 0.029 |
| September 30, 2023 | 0.0389 |
| June 30, 2023 | 0.033 |
| March 31, 2023 | 0.0255 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.0278 |
| September 30, 2022 | 0.0254 |
| June 30, 2022 | 0.0235 |
| March 31, 2022 | 0.0215 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
| Biogen, Inc. | 0.4433 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 220.67M |
| Total Liabilities (Quarterly) | 9.531M |
| Shareholders Equity (Quarterly) | 211.14M |
| Current Ratio | 27.59 |
| Net Debt Paydown Yield | 0.01% |